Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease

Lenglet M., Robriquet F., Schwarz K., Camps C., Couturier A., Hoogewijs D., Buffet A., Knight SJL., Gad S., Couvé S., Chesnel F., Pacault M., Lindenbaum P., Job S., Dumont S., Besnard T., Cornec M., Dreau H., Pentony M., Kvikstad E., Deveaux S., Burnichon N., Ferlicot S., Vilaine M., Mazzella J-M., Airaud F., Garrec C., Heidet L., Irtan S., Mantadakis E., Bouchireb K., Debatin K-M., Redon R., Bezieau S., Bressac-de Paillerets B., Teh BT., Girodon F., Randi M-L., Putti MC., Bours V., Van Wijk R., Göthert JR., Kattamis A., Janin N., Bento C., Taylor JC., Arlot-Bonnemains Y., Richard S., Gimenez-Roqueplo A-P., Cario H., Gardie B.

Key Points Mutations in a VHL cryptic exon may be found in patients with familial erythrocytosis or VHL disease. Synonymous mutations in VHL exon 2 may induce exon skipping and cause familial erythrocytosis or VHL disease.

DOI

10.1182/blood-2018-03-838235

Type

Journal article

Journal

Blood

Publisher

American Society of Hematology

Publication Date

02/08/2018

Volume

132

Pages

469 - 483

Permalink Original publication